Skip to content

KOD

Kodiak Sciences Inc.

NASDAQ · USHealthcareBiotechnology
$40.87-4.15%

Price as of Jul 20, 2026

KOD capital

Kodiak Sciences Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
1.39x
Net debt / equity
-0.12x
Debt / assets
0.51x
Debt / EBITDA
-0.78x
Net debt / EBITDA
0.07x

Liquidity & coverage

Current ratio
3.54x
Quick ratio
3.54x
Cash ratio
3.42x
Interest coverage
EBITDA / interest
Working capital
$125.7M

Cash & dividend

FCF / debt
-0.95x
Cash flow / debt
-0.94x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.